Alogliptin or a pharmaceutically acceptable salt thereof

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

发明人:

申请号：

NL300640

公开号：

NL300640I2

申请日:

2014.02.11

申请国别(地区):

NL

年份:

2018

代理人:

摘要：

Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound comprising Formula I: <；CHEM>； wherein M is N or CR4； Q<；1>； and Q<；2>； are each independently selected from the group consisting of CO, SO, SO2, and C=NR9； and each R1, R2, R3, R4 and R9 are as defined herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/